NCT04043676 2019-08-02Consolidation Treatment With Ponatinib 15 mg on Treatment Free-Remission Rate in Patients With Chronic Myeloid LeukemiaFundaciĆ³n TeĆ³filo Hernando, SpainPhase 2 Unknown40 enrolled